Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

E Basch, BB Reeve, SA Mitchell… - Journal of the …, 2014 - academic.oup.com
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …
被引用次数：910 相关文章

[引用][C] Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

E Basch, BB Reeve, SA Mitchell, SB Clauser… - JNCI Journal of the …, 2014 - cir.nii.ac.jp
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the
Common Terminology Criteria for Adverse Events (PRO-CTCAE) | CiNii Research CiNii 国立 …

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

E Basch, BB Reeve, SA Mitchell… - Journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

E Basch, BB Reeve, SA Mitchell… - JNCI: Journal of the …, 2014 - search.ebscohost.com
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …
[PDF] academia.edu

[PDF][PDF] Development of the national Cancer Institute's Patient-reported outcomes Version of the Common terminology Criteria for adverse events (Pro-CtCae)

E Basch, BB Reeve, SA Mitchell, SB Clauser… - 2014 - academia.edu
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …
[HTML] nih.gov

[HTML][HTML] Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

E Basch, BB Reeve, SA Mitchell… - JNCI Journal of the …, 2014 - ncbi.nlm.nih.gov
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

E Basch, BB Reeve, SA Mitchell… - Journal of the …, 2014 - europepmc.org
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …

Development of the national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

E Basch, BB Reeve, SA Mitchell… - Journal of the …, 2014 - mayoclinic.elsevierpure.com
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …

Development of the national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

E Basch, BB Reeve, SA Mitchell… - Journal of the …, 2014 - mdanderson.elsevierpure.com
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …
[PDF] researchgate.net

[PDF][PDF] Development of the national Cancer Institute's Patient-reported outcomes Version of the Common terminology Criteria for adverse events (Pro-CtCae)

E Basch, BB Reeve, SA Mitchell, SB Clauser… - 2014 - researchgate.net
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …